北京京仪自动化装备技术股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险。公司已在报告中详细描述可 能存在的相关风险，敬请查阅"第三节 管理层讨论与分析"之"四、风险因素"部分内容。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人沈洪亮、主管会计工作负责人郑帅男及会计机构负责人（会计主管人员）和琳 琳声明：保证半年度报告中财务报告的真实、准确、完整。 公司代码：688652 公司简称：京仪装备 北京京仪自动化装备技术股份有限公司 2025 年半年度报告 1 / 170 北京京仪自动化装备技术股份有限公司2025 年半年度报告 √适用 □不适用 本报告所涉及的公司未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺，请投 资者注意投资风险。 九、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 六、 董事会决议通过的本报告期 ...

证券代码：688652 证券简称：京仪装备 公告编号：2025-028 根据《上市公司募集资金监管规则》和《上海证券交易所科创板上市公司自 律监管指引第1号——规范运作》有关规定，北京京仪自动化装备技术股份有限 公司（以下简称"公司"或"本公司"）董事会编制了2025年半年度（以下简称 "报告期"或"本报告期"）募集资金存放与实际使用情况专项报告，说明如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于同意北京京仪自动化装备技术股份有限公 司首次公开发行股票注册的批复》（证监许可〔2023〕1778号）核准，本公司获 准向社会公开发行普通股（A股）4,200万股。本次发行委托国泰君安证券股份有 限公司承销，发行价为每股31.95元，实际发行股份数量4,200万股。截至2023 年11月24日，本公司共募集资金1,341,900,000.00元，扣除各项发行费用 75,646,501.03元后，募集资金净额为1,266,253,498.97元。 上述募集资金净额已经致同会计师事务所（特殊普通合伙）以致同验字（2023） 第110C000538号《验资报告》验证。 （ ...

北京京仪自动化装备技术股份有限公司 关于 2025 年度提质增效重回报专项行动方案的 半年度评估报告 北京京仪自动化装备技术股份有限公司（以下简称"公司"）为践行以 "投资者为本"的上市公司发展理念，维护全体股东利益，基于对公司发展 前景的信心和对公司长期投资价值的认可，公司制定了《北京京仪自动化装 备技术股份有限公司 2025 年度"提质增效重回报"行动方案》（以下简称"行 动方案"），努力实现经营业绩持续稳定的增长，为客户、股东、员工及其 他社会各方创造价值，积极回报利益相关方。2025 年上半年，行动方案主要 举措的落实（进展）及成效情况如下： （一）加强投资者沟通 一、"提升经营质量，加快新质生产力"方面 2025年上半年，公司实现营业收入734,644,489.61元，较上年同期增 长45.38%；实现归属于上市公司股东的净利润90,004,386.31元，较上年同 期增长12.84%。公司围绕战略方向，持续加强研发投入，上半年研发投入 72,400,230.30元，较上年同期增长61.93%。 2025年上半年，公司申请专利及软件著作权等47件，获得专利及软件 著作权等37件。其中获得发明专利3件 ...

688652 2025-025 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京京仪自动化装备技术股份有限公司（以下简称"公司"）于2025年8月28 日召开第二届董事会第八次会议，审议通过了《关于取消监事会并修订<公司章程 >的议案》《关于制定、修订、废止公司部分治理制度的议案》等议案。现将有关 情况公告如下： 一、取消公司监事会并修订《公司章程》及相关制度的原因及依据 根据《中华人民共和国公司法》（以下简称《公司法》）、《上市公司章程 指引（2025年修订）》等法律法规的规定，结合公司实际情况及需求，公司将不 再设置监事会，监事会的职权由董事会审计委员会行使，《北京京仪自动化装备 技术股份有限公司监事会议事规则》（以下简称《监事会议事规则》）等监事会 相关制度相应废止。同时，根据法律法规及规章制度的规定，公司对《北京京仪 自动化装备技术股份有限公司章程》（以下简称《公司章程》）及其附件《北京 京仪自动化装备技术股份有限公司股东大会议事规则》《北京京仪自动化装备技 术股份有限公司董事会议事规则》等治理制度亦作出相应修 ...

证券代码：688652 证券简称：京仪装备 公告编号：2025-027 北京京仪自动化装备技术股份有限公司 关于 2025 年半年度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、计提减值准备的情况概述 北京京仪自动化装备技术股份有限公司(以下简称"公司")根据《企业会计 准则第 8 号--资产减值》和相关会计政策的规定，结合公司的实际情况，为客 观、公允地反映公司截至 2025 年 6 月 30 日的财务状况和 2025 年 1-6 月的经营 成果，公司对截至 2025 年 6 月 30 日合并范围内存在减值迹象的资产进行了减值 测试，预计 2025 年 1-6 月公司计提各类信用减值损失及资产减值损失共计人民 币 25,114,381.71 元，具体情况如下： 二、计提减值准备事项的具体说明 （一） 信用减值损失 公司以预期信用损失为基础，对应收票据、应收账款、其他应收款进行了减 值测试。经测试，本次需计提信用减值损失金额共计 13,459,607.14 元。 单位：人民币元 项目 2025 ...

格隆汇8月28日丨京仪装备(688652.SH)公布半年度报告，营业收入7.3亿元，同比增长45.38%，归属于 上市公司股东的净利润9000万元，同比增长12.84%，归属于上市公司股东的扣除非经常性损益的净利 润7521.66万元，同比增长26.21%。 ...

京仪装备公告，2025年上半年营业收入7.35亿元，同比增长45.38%。净利润9000.44万元，同比增长 12.84%。 ...

Core Insights - The financing balance of the Sci-Tech Innovation Board increased by 1.9 billion yuan compared to the previous trading day, marking a continuous increase for 33 trading days [1] - The total margin balance reached 218 billion yuan, with a financing balance of 217.25 billion yuan and a securities lending balance of 755 million yuan [1] - The stocks with the highest financing balances include SMIC at 11 billion yuan, followed by Cambrian and Haiguang Information at 9.2 billion yuan and 7.2 billion yuan respectively [1] Financing Balance Summary - 270 stocks saw an increase in financing balance, while 314 stocks experienced a decrease [1] - Notable increases in financing balance were observed in Maide Medical (41.95%), Jingyi Equipment (32.05%), and Anbotong (28.86%) [1][2] - Significant decreases were noted in Yifang Bio (-29.85%), Kangwei Century (-21.02%), and Jushi Chemical (-20.70%) [1][2] Securities Lending Balance Summary - The highest securities lending balance was recorded for Cambrian at 48 million yuan, followed by Haiguang Information and SMIC at 39 million yuan and 32 million yuan respectively [2] - 117 stocks saw an increase in securities lending balance, while 158 stocks experienced a decrease [2] - The largest increases in securities lending balance were in Bairen Medical (299.55%), Jucheng Technology (127.31%), and Yihua Tong (112.52%) [2] - The largest decreases were in Tianzhihang (-54.20%), Diaomicro (-50.23%), and Funeng Technology (-46.69%) [2]

Core Viewpoint - 京仪装备's stock price decreased by 5.01% to 74.18 CNY per share, with a trading volume of 138 million CNY and a market capitalization of 12.462 billion CNY as of August 26 [1] Company Overview - Beijing Jingyi Automation Equipment Technology Co., Ltd. was established on June 30, 2016, and listed on November 29, 2023 [1] - The company specializes in the research, production, and sales of semiconductor equipment, with main products including semiconductor temperature control equipment (Chiller), process exhaust treatment equipment (Local Scrubber), and wafer sorting equipment (Sorter) [1] - Revenue composition: 61.25% from semiconductor temperature control equipment, 31.51% from process exhaust treatment equipment, 3.68% from spare parts and support equipment, 2.39% from wafer sorting equipment, and 1.16% from maintenance and repair services [1] Shareholder Analysis - Qianhai Kaiyuan Fund's public utility stock (005669) is among the top ten circulating shareholders of 京仪装备, having reduced its holdings by 547,400 shares to 3.7654 million shares, representing 3.68% of circulating shares [2] - Estimated floating loss for Qianhai Kaiyuan Fund today is approximately 14.7228 million CNY [2] - Qianhai Kaiyuan Fund (005669) was established on March 23, 2018, with a current scale of 9.658 billion CNY and year-to-date returns of 25.33% [2] Fund Performance - Qianhai Kaiyuan High-end Equipment Manufacturing Mixed A (001060) reduced its holdings in 京仪装备 by 79,500 shares, holding 101,600 shares, which accounts for 4.49% of the fund's net value [4] - Estimated floating loss for this fund today is approximately 397,300 CNY [4] - Qianhai Kaiyuan High-end Equipment Manufacturing Mixed A (001060) was established on March 27, 2015, with a current scale of 118 million CNY and year-to-date returns of 38.32% [4]

Group 1 - Company announced the termination of its plan to issue convertible bonds, originally intended to raise no more than 493 million yuan for semiconductor-related projects and working capital [1] - The decision to withdraw the application was based on changes in the external environment and the company's overall development strategy [1] - The company had previously faced inquiries from the Shanghai Stock Exchange regarding its fundraising plans [1] Group 2 - The company plans to invest 460 million yuan to expand its process exhaust treatment equipment production line and add vacuum/temperature control equipment business [1] - The utilization rate of the new process exhaust treatment equipment is projected to be only 63.62% in 2024, indicating potential challenges in absorbing new production capacity due to cyclical fluctuations in the semiconductor industry [1] - As of the end of 2024, accounts receivable aged over one year accounted for 46.53%, with the company's accounts receivable turnover rate below the industry average [1] Group 3 - The overdue rate of accounts receivable reached 20.98% by the end of February 2025, raising concerns about the company's credit risk [1] - The company's bad debt provision ratio is 2.6% higher than the industry average, despite having similar policies to comparable companies [1] - The presence of customers with litigation or bankruptcy issues has contributed to an accumulating risk in customer repayments, highlighting a mismatch between revenue recognition timing and cash flow [1]